4.7 Article

Fluvastatin as an adjuvant to pegylated interferon and ribavirin in HIV/hepatitis C virus genotype 1 co-infected patients: an open-label randomized controlled study

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Review Medicine, General & Internal

Statins for the Prevention and Treatment of Infections A Systematic Review and Meta-analysis

Imad M. Tleyjeh et al.

ARCHIVES OF INTERNAL MEDICINE (2009)

Article Virology

Influence of the HCV Subtype on the Virological Response to Pegylated Interferon and Ribavirin Therapy

Florence Legrand-Abravanel et al.

JOURNAL OF MEDICAL VIROLOGY (2009)

Article Gastroenterology & Hepatology

Does fluvastatin favour HCV replication in vivo? A pilot study on HIV-HCV coinfected patients

L. Milazzo et al.

JOURNAL OF VIRAL HEPATITIS (2009)

Article Gastroenterology & Hepatology

Do statins reduce hepatitis C RNA titers during routine clinical use?

Kimberly A. Forde et al.

WORLD JOURNAL OF GASTROENTEROLOGY (2009)

Letter Immunology

Safety of statin therapy in HIV/hepatitis C virus-coinfected patients

Laura Milazzo et al.

JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2007)

Article Infectious Diseases

The treatment of chronic hepatitis C in HIV-infected patients: a meta-analysis

A. I. Kim et al.

HIV MEDICINE (2007)

Article Gastroenterology & Hepatology

Atorvastatin does not exhibit antiviral activity against HCV at conventional doses: A pilot clinical trial

Jacqueline G. O'Leary et al.

HEPATOLOGY (2007)

Article Gastroenterology & Hepatology

Correlation between beta-lipoprotein levels and outcome of hepatitis C treatment

Kavitha Gopal et al.

HEPATOLOGY (2006)

Article Gastroenterology & Hepatology

Incidence of statin hepatotoxicity in patients with hepatitis C

Shirin Khorashadi et al.

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2006)

Article Gastroenterology & Hepatology

Different anti-HCV profiles of statins and their potential for combination therapy with interferon

Masanori Ikeda et al.

HEPATOLOGY (2006)

Article Multidisciplinary Sciences

Hepatitis C virus RNA replication is regulated by host geranylgeranylation and fatty acids

SB Kapadia et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)

Review Gastroenterology & Hepatology

Diagnosis, management, and treatment of hepatitis C

DB Strader et al.

HEPATOLOGY (2004)

Article Medicine, General & Internal

Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection in HIV-infected patients

FJ Torriani et al.

NEW ENGLAND JOURNAL OF MEDICINE (2004)

Article Multidisciplinary Sciences

Disruption of hepatitis C virus RNA replication through inhibition of host protein geranylgeranylation

J Ye et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)

Article Biochemistry & Molecular Biology

Statins as a newly recognized type of immunomodulator

B Kwak et al.

NATURE MEDICINE (2000)